Trials / Conditions / PTLD
PTLD
6 registered clinical trials studyying PTLD.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | PTLD: Multicentric Retrospective Study NCT06422715 | Fondazione Italiana Linfomi - ETS | — |
| Withdrawn | A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) NCT04138875 | Yale University | Phase 2 |
| Unknown | Low-dose CD20 Monoclonal Antibody Injection in Preemptive Treatment of PTLD in Patients With EBV-HLH/CAEBV NCT05258136 | Beijing Friendship Hospital | N/A |
| Withdrawn | Single Agent Obinutuzumab in Relapsed/Refractory Post-Transplant Lymphoproliferative Disorder (PTLD) NCT03086395 | Case Comprehensive Cancer Center | Phase 2 |
| Completed | CNTRP POSITIVE Study NCT02318030 | The Hospital for Sick Children | — |
| Completed | Risk Stratified Sequential Treatment for CD20-positive PTLD NCT00590447 | Charite University, Berlin, Germany | Phase 2 |